Protein Key to Bladder Cancer Spread, Potential Drug Target

	Tweet

By demonstrating that a protein - a growth factor called proepithelin - plays a crucial role in the spread of bladder cancer, scientists at Jefferson Medical College and Jefferson’s Kimmel Cancer Center may have identified a potential target for drugs.

“The fact that proepithelin doesn’t appear to strongly promote cell proliferation, but instead promotes migration and invasion - two crucial steps leading to metastasis - suggests that it could be critical for the passage of a cancer from a noninvasive to an invasive phenotype,” says Andrea Morrione, Ph.D., research assistant professor of urology at Jefferson Medical College of Thomas Jefferson University and Jefferson’s Kimmel Cancer Center in Philadelphia.

In some cases, he notes, proepithelin might be used as a marker for bladder cancer. He and his colleagues report their findings July 15, 2006 in the journal Cancer Research.

Proepithelin is found in higher-than-normal levels in breast, ovarian and renal cancers, in addition to deadly brain cancers known as glioblastomas. It plays important roles in development, cell movement and tumor formation.

The American Cancer Society estimates that 61,420 new cases of bladder cancer will be found in the United States during 2006, making it the fifth most common cancer in this country. About 13,060 people will die of the disease. While it is treatable, especially if caught early, the cancer often returns and spreads to other areas of the body, and little is known about the molecular mechanisms behind its formation.

Dr. Morrione, along with a team including Renato Iozzo, M.D., professor of pathology, anatomy and cell biology, Raffaele Baffa, M.D., associate professor of urology, and Leonard Gomella, M.D., professor and chair of urology, all at Jefferson Medical College, knew that proepithelin was important in cell migration and wanted to investigate its potential role in bladder tumor formation.

In the study, using 5637 bladder cancer cells (cells from a type of bladder cancer), the group showed that proepithelin promoted migration of the bladder cancer cells and stimulated wound closure and invasion. He notes that looking at wound healing - “the ability of the cells to migrate and close gaps” - was another technique used to confirm proepithelin’s role.

When they looked more closely at the molecular pathways involved in bladder cancer formation, they discovered that proepithelin turned on a common pathway called MAP kinase. Dr. Morrione believes that proepithelin will be found to have similar roles in other cancers.

He notes that one next step in the work is to verify whether or not proepithelin could be a marker in bladder tumors to use to predict metastasis. Bladder tumors are sometimes difficult to treat because of recurrence, he says. “There is a need for a non-invasive test for early detection of bladder tumors.”

Thomas Jefferson University

RELATED STORIES:
Genetic analysis may predict risk of invasive bladder cancer   Cholesterol drug inhibits cancer cells in lab   Sales jobs tied to bladder cancer risk   MDCT Shows Potential for Detecting Bladder Cancer Without Surgery or Contrast   Scientists find one reason why bladder cancer hits more men   Brochure Helps Patients Understand Treatments for Bladder Cancer   Less bladder cancer in frequent painkiller users   Certain Ecologic Factors Associated with Greater Risk of Bladder Cancer   Arsenic cancer risk still high decades later in Chile region   New Biomarker Test Could Predict Outcome for Bladder Cancer Patients   Patients unaware of link between smoking and bladder cancer   Bladder Cancer Study Determines Optimal Treatment   Early menopause related to bladder cancer risk   Measurement of Urinary Protein Can Help Detect Recurrent Bladder Cancer   Not enough evidence for bladder cancer screening   Survivors of Childhood Cancers Treated with Cyclophosphamide More Likely to Develop Bladder Cancer   New made-in-Canada therapy for bladder cancer shows promising results   Researcher Says Improved Detection of Bladder Tumors Reduces Cancer Recurrence   New Trial Targets Kidney Cancer Drug in Bladder Cancer   New Investigational Treatment for Bladder Cancer, Identified with New Research Model   Retired firefighters could be at increased risk for developing bladder cancer   Blood test may find markers of bladder cancer risk

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]